「dry」の検索結果
46件：21～25件目を表示
もしかして
-
千寿製薬株式会社
700（PDF） 2026年04月06日 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） 2025年12月22日 Obtained manufacturing and marketing appro...
https://www.senju.co.jp/chinese/ -
論文投稿実績 | 研究開発活動 | 千寿製薬株式会社
uble-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2 1: Senju Pharmaceutical Co...
https://www.senju.co.jp/rd/thesis/ -
千寿製薬株式会社
700（PDF） 2026年04月06日 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） 2025年12月22日 Obtained manufacturing and marketing appro...
http://www.senju.co.jp/chinese/ -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
uitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Japan Completed jRCT2031250103 Dry Eye Disease 3 SJP-0132 China Completed NCT06717152 Healthy Volunteers 1 SJP-0170 Japan Completed...
http://www.senju.co.jp/english/rd/trial.html -
Publications | Research & Development | SENJU Pharmaceutica
uble-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2 1: Senju Pharmaceutical Co...
http://www.senju.co.jp/english/rd/thesis/